Avanos Medical Inc
General ticker "AVNS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $842.8M
Avanos Medical Inc follows the US Stock Market performance with the rate: 25.0%.
Estimated limits based on current volatility of 2.2%: low 15.83$, high 16.53$
Factors to consider:
- Current price 29.4% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [21.37$, 33.34$]
- 2023-12-31 to 2024-12-30 estimated range: [22.70$, 35.46$]
Financial Metrics affecting the AVNS estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.65
- Positive: -3.48 < Investing cash flow per share, $ of -2.89
- Negative: Industry operating cash flow per share per price (median), % of -7.05 <= 3.85
- Negative: Industry inventory ratio change (median), % of 2.06 > 0.49
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.75
Short-term AVNS quotes
Long-term AVNS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $564.70MM | $681.10MM | $660.00MM |
| Operating Expenses | $603.70MM | $645.60MM | $655.80MM |
| Operating Income | $-39.00MM | $35.50MM | $4.20MM |
| Non-Operating Income | $-3.10MM | $-8.80MM | $-12.10MM |
| Interest Expense | $3.30MM | $10.00MM | $15.00MM |
| R&D Expense | $32.30MM | $30.60MM | $27.20MM |
| Income(Loss) | $-42.10MM | $26.70MM | $-7.90MM |
| Taxes | $-11.20MM | $5.20MM | $2.00MM |
| Other Income(Loss) | $37.20MM | $29.00MM | $-51.90MM |
| Profit(Loss) | $6.30MM | $50.50MM | $-61.80MM |
| Stockholders Equity | $1,270.60MM | $1,291.20MM | $1,236.30MM |
| Inventory | $150.30MM | $190.30MM | $163.20MM |
| Assets | $1,603.60MM | $1,786.90MM | $1,692.40MM |
| Operating Cash Flow | $87.30MM | $90.90MM | $32.40MM |
| Capital expenditure | $21.00MM | $19.30MM | $17.80MM |
| Investing Cash Flow | $-21.00MM | $-135.40MM | $21.60MM |
| Financing Cash Flow | $-55.30MM | $56.70MM | $-94.20MM |
| Earnings Per Share* | $0.13 | $1.08 | $-1.33 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.